Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

BACKGROUND: We assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by using the worst-case scenario method, and compared the worst-case dose distributions with the appearance of locally re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhengfei, Liu, Wei, Gillin, Michael, Gomez, Daniel R, Komaki, Ritsuko, Cox, James D, Mohan, Radhe, Chang, Joe Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029832/
https://www.ncbi.nlm.nih.gov/pubmed/24886059
http://dx.doi.org/10.1186/1748-717X-9-108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029832/
https://www.ncbi.nlm.nih.gov/pubmed/24886059
http://dx.doi.org/10.1186/1748-717X-9-108

Ejemplares similares